Nonsteroidal Anti-Inflammatory Drug-Associated Upper Gastrointestinal Lesions in Rheumatoid Arthritis Patients: Relationships to Gastric Histology, Helicobacter pylori Infection, and Other Risk Factors for Peptic Ulcer

References

• Marshall BJ. Helicobacter pylori in peptic ulcer: have Koch’s postulates been fulfilled? Ann Intern Med 1995;27:565–8.
   Google Scholar
• Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984–9.
   PubMed Web of Science ®Google Scholar
• Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307–19.
   PubMed Web of Science ®Google Scholar
• Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum 1995;38:5–18.
   Google Scholar
• Taha AS, Russell RI. Helicobacter pylori and nonsteroidal antiinflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut 1993;34:580–3.
   PubMedGoogle Scholar
• Scheiman JM. NSAIDs, gastrointestinal injury, and cyto-protection. Gastroenterol Clin North Am 1996;25:279–98.
   PubMed Web of Science ®Google Scholar
• Heresbach D, Raoul JL, Bretagne JF, Minet J, Donnio PY, Ramee MP, et al. Helicobacter pylori: a risk and severity factor of nonsteroidal anti-inflammatory drug induced gastropathy. Gut 1992;33:1608–11.
   PubMedGoogle Scholar
• Farah D, Sturrock RD, Russell RI. Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis 1988;47:478–80.
   PubMed Web of Science ®Google Scholar
• Dixon MF, O’Connor HJ, Axon ATR, King RFJG, Johnston D. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986;39:524–30.
   PubMed Web of Science ®Google Scholar
• Sobala GM, King RFG, Axon ATR, Dixon MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990;43:303–6.
   PubMed Web of Science ®Google Scholar
• Sobala GM, O’Connor HJ, Dewar EP, King RFG, Axon AT, Dixon MF. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993;46:235–40.
   PubMed Web of Science ®Google Scholar
• Mottonen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the ‘saw tooth’ strategy. Arhritis Rheum 1996;39:996–1005.
   Google Scholar
• Taha AS, Strurrock RD, Russell RI. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine and non-steroidal anti-inflammatory drugs. Am J Gastroenterol 1992;87:1732–5.
   Google Scholar
• El-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, et al. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with suplhasalazine. Gut 1994;35:1385–8.
   Google Scholar
• Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal antiinflammatory drugs. Ann Intern Med 1991;114:737–40.
   Google Scholar
• Savary M, Miller G, editors. The esophagus. Handbook and atlas of endoscopy. Solothurn, Switzerland: Gassman Verlag AG; 1978.
   Google Scholar
• Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209–22.
   PubMed Web of Science ®Google Scholar
• Phull PS, Price AB, Stephens J, Rathbone BJ, Jacyna MR. Histology of chronic gastritis with and without duodenitis in patients with Helicobacter pylori infection. J Clin Pathol 1996;49:377–80.
   Google Scholar
• McCarthy CJ, McDermott M, Hourihane D, O’Morain C. Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection. J Clin Pathol 1995;48:61–3.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Ropes MW. Diagnostic criteria for rheumatoid arthritis 1958 revision. Ann Rheum Dis 1959;18:49–53.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz PW, Kraines RG. Measurement of patient outcome in arthritis. Arthritis Rheum 1987;23:137–45.
   Google Scholar
• Janssen BA, Dijkmans BAC, van der Sluys FA, van der Wielen JGB, Havenga K, Vandenbroucke JP, et al. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol 1992;31:747–52.
   Google Scholar
• Borody TJ, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol 1992;87:1403–6.
   PubMed Web of Science ®Google Scholar
• Nobunaga M. NSAID-induced GI damage: a serious problem? In: Nasution AR, Darmawan J, Isbagio H, editors. Proceedings of the 7th APLAR Congress of Rheumatology; 1992 Sep 13–18; Bali. Tokyo: Churchill Livingstone; 1991. p. 319.
   Google Scholar
• Goggin PM, Collins DA, Jazrawi RP, Jackson PA, Corbishley CM, Bourke BE, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and nonsteroidal antiinflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993;34:1677–80.
   PubMed Web of Science ®Google Scholar
• Kim JG, Graham DY, The Misoprostol Study Group. Helicobacter pylori infection and development of gastric and duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994;89:203–7.
   Google Scholar
• Laine L, Marin-Sorensen M, Weinstein WM. Nonsteroidal antiinflammatory drug associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992;87:1398–402.
   PubMed Web of Science ®Google Scholar
• Chan FKL, Sung JJY, Chung SCS, To KF, Yung MY, Leung VKS, et al. Randomised trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975–9.
   PubMed Web of Science ®Google Scholar
• Schallross TM, Rathbone BJ, Wyatt JI, Heatley RV. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1990;4:515–22.
   PubMedGoogle Scholar
• Quinn CM, Bjarnason I, Price AB. Gastritis in patients on nonsteroidal anti-inflammatory drugs. Histopathology 1993;23: 341–8.
   Google Scholar
• El-Zimaity HMT, Genta RM, Graham DY. Histological features do not define NSAID-induced gastritis. Hum Pathol 1996;27: 1348–54.
   Google Scholar
• Al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy 1996;28:229–33.
   Google Scholar
• Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991;91:213–22.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787–96.
   Google Scholar
• Taha AS, Morran C, Sturrock RD, Russell RI. The Health Assessment Questionnaire as predictor of nonsteroidal peptic ulceration. Br J Rheumatol 1993;32:135–8.
   PubMedGoogle Scholar
• Roth SH. NSAID gastropathy. Arch Intern Med 1996;156:1623–8.
   PubMedGoogle Scholar
• Konturek JW, Dembinski A, Stoll R, Domschke W, Konturek SJ. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation. Gut 1994;35:1197–204.
   Google Scholar